Adipiplon

From WikiMD's Food, Medicine & Wellness Encyclopedia

Adipiplon.svg

Adipiplon is a nonbenzodiazepine hypnotic and anxiolytic drug that was under development for the treatment of insomnia and anxiety disorders. It acts as a GABAA receptor agonist, specifically targeting the α3 subunit of the receptor, which is believed to be associated with the drug's anxiolytic effects.

Mechanism of Action[edit | edit source]

Adipiplon works by enhancing the activity of the gamma-aminobutyric acid (GABA) neurotransmitter at the GABAA receptor. This receptor is a ligand-gated ion channel that, when activated, allows the influx of chloride ions into the neuron, leading to hyperpolarization and decreased neuronal excitability. By selectively targeting the α3 subunit, adipiplon aims to provide anxiolytic effects with potentially fewer side effects compared to non-selective GABAA receptor agonists.

Clinical Development[edit | edit source]

Adipiplon was being developed by Neurogen Corporation for the treatment of insomnia and anxiety disorders. However, its development was discontinued after clinical trials. The reasons for discontinuation included issues related to efficacy, safety, and tolerability.

Pharmacokinetics[edit | edit source]

The pharmacokinetic profile of adipiplon includes its absorption, distribution, metabolism, and excretion. Adipiplon is administered orally and undergoes hepatic metabolism. The primary route of excretion is through the renal system.

Side Effects[edit | edit source]

Common side effects of adipiplon observed in clinical trials included drowsiness, dizziness, and headache. As with other GABAA receptor agonists, there is a potential for dependence and withdrawal symptoms upon discontinuation.

See Also[edit | edit source]

References[edit | edit source]

External Links[edit | edit source]

-


Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD